Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Neuroscience ; 186: 39-47, 2011 Jul 14.
Artigo em Inglês | MEDLINE | ID: mdl-21497179

RESUMO

Iron surcharge may induce an oxidative stress-based decline in several neurological functions. In addition, electromagnetic fields (EMF) of frequencies up to about 100 kHz, emitted by electric/electronic devices, have been suggested to enhance free radical production through an iron dependent pathway. The purpose of this study was therefore to determine a possible relationship between iron status, exposure to EMF, and brain oxidative stress in young adult rats. Samples were micro-dissected from prefrontal cortex, hippocampus, striatum, and cerebellum after chronic saline or iron overload (IO) as well as after chronic sham exposure or exposure to a 150 kHz EMF or after combining EMF exposure with IO. The brain samples were used to monitor oxidative stress-induced lipid peroxidation and activity of the antioxidant enzymes superoxide dismutase and catalase. While IO did not induce any oxidative stress in young adult rats, it stimulated antioxidant defenses in the cerebellum and prefrontal cortex in particular. On the contrary, EMF exposure stimulated lipid peroxidation mainly in the cerebellum, without affecting antioxidant defenses. When EMF was coapplied with IO, lipid peroxidation was further increased as compared to EMF alone while the increase in antioxidant defenses triggered by the sole IO was abolished. These data suggest that EMF exposure may be harmful in young adults by impairing the antioxidant defenses directed at preventing iron-induced oxidative stress.


Assuntos
Adaptação Fisiológica/efeitos da radiação , Encéfalo/metabolismo , Encéfalo/efeitos da radiação , Campos Eletromagnéticos/efeitos adversos , Sobrecarga de Ferro/metabolismo , Estresse Oxidativo/efeitos da radiação , Adaptação Fisiológica/fisiologia , Fatores Etários , Animais , Doença Crônica , Modelos Animais de Doenças , Sobrecarga de Ferro/etiologia , Sobrecarga de Ferro/fisiopatologia , Masculino , Estresse Oxidativo/fisiologia , Ratos , Ratos Wistar
2.
Mol Cell Neurosci ; 40(4): 463-73, 2009 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-19340933

RESUMO

Evidence have accumulated that reverse glutamate uptake plays a key role in the pathophysiology of cerebral ischemia. Here, we investigated the effects of glial glutamate transporter dysfunction on neuronal survival using the substrate inhibitor of glutamate transporters, L-trans-pyrrolidine,2-4,dicarboxylate (PDC), that partly mimics reverse glutamate uptake. On mice primary cortical co-cultures of neurons and astrocytes, PDC treatment triggered an elevation of extracellular glutamate concentration, induced neuronal calcium influx and a massive NMDA receptor (NMDAR) mediated-neuronal death without having any direct agonist activity on NMDARs. We investigated the NMDAR subpopulation activated by PDC-induced glutamate release. PDC application led to the activation of both subtypes of NMDARs but the presence of astrocytes was required to activate NMDARs located extra-synaptically. Extrasynaptic NMDAR activation was also confirmed by the loss of neuronal mitochondrial membrane potential and the inhibition of pro-survival p-ERK signalling pathway. These data suggest that reverse glial glutamate uptake may trigger neuronal death through preferential activation of extrasynaptic NMDAR-related pathways.


Assuntos
Morte Celular/fisiologia , Ácido Glutâmico/metabolismo , Neuroglia/metabolismo , Neurônios/metabolismo , Receptores de N-Metil-D-Aspartato/metabolismo , Sistema X-AG de Transporte de Aminoácidos/metabolismo , Animais , Células Cultivadas , Técnicas de Cocultura , Ácidos Dicarboxílicos/metabolismo , Ativação Enzimática , MAP Quinases Reguladas por Sinal Extracelular/metabolismo , Proteína Glial Fibrilar Ácida/metabolismo , Humanos , Camundongos , Proteínas Associadas aos Microtúbulos/metabolismo , Mitocôndrias/metabolismo , Neuroglia/citologia , Neurônios/citologia , Inibidores da Captação de Neurotransmissores/metabolismo , Pirrolidinas/metabolismo , Proteínas Recombinantes de Fusão/genética , Proteínas Recombinantes de Fusão/metabolismo
3.
Ann Fr Anesth Reanim ; 24(5): 502-9, 2005 May.
Artigo em Francês | MEDLINE | ID: mdl-15885966

RESUMO

This review describes reactive oxygen species (ROS), their production and effects on crucial biological molecules, the different lines of defense against oxidative stress, with particular attention to glutathione, the main antioxidant in the brain, which neuronal synthesis seems to be dependent on astrocytic precursors. It also focuses on the different ways by which glutamate may induce oxidative stress in the brain. The different mechanisms leading to ROS production, activated during the excitotoxic cascade, are described. Oxidative glutamate toxicity is also briefly described. A novel form of oxidative glutamate toxicity by depletion of transported glutamate that we recently evidenced is detailed. This toxicity induced by pharmacological reversal of glutamate transport, which mimics glutamate transport reversal occurring in ischemia, involves glutathione depletion and oxidative stress, leading to delayed death of cultured striatal astrocytes differentiated by dibutyryl-cAMP, probably through apoptotic processes. Evidence suggesting that this oxidative glutamate toxicity by depletion of transported glutamate is very likely occurring in vivo and its consequences on neuronal survival are discussed.


Assuntos
Astrócitos/efeitos dos fármacos , Encéfalo/patologia , Ácido Glutâmico/farmacologia , Neurônios/patologia , Antioxidantes/fisiologia , Astrócitos/metabolismo , Astrócitos/patologia , Transporte Biológico/efeitos dos fármacos , Encéfalo/metabolismo , Bucladesina/farmacologia , Comunicação Celular , Diferenciação Celular , Sobrevivência Celular , Células Cultivadas/patologia , Ácido Glutâmico/metabolismo , Glutationa/metabolismo , Humanos , Peroxidação de Lipídeos , Mitocôndrias/metabolismo , Proteínas do Tecido Nervoso/metabolismo , Doenças Neurodegenerativas/metabolismo , Doenças Neurodegenerativas/patologia , Estresse Oxidativo , Espécies Reativas de Oxigênio
4.
J Neurochem ; 74(3): 909-19, 2000 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-10693921

RESUMO

This study compared the effects of the disruption of the two main presumably glutamatergic striatal inputs, the corticostriatal and thalamostriatal pathways, on GLT1 expression in the rat striatum, using in situ hybridization and immunohistochemistry. Unilateral ibotenate-induced thalamic lesion produced no significant changes in striatal GLT1 mRNA labeling and immunostaining as assessed at 5 and 12 days postlesion. In contrast, significant increases in both parameters were measured after bilateral cortical lesion by superficial thermocoagulation. GLT1 mRNA levels increased predominantly in the dorsolateral part of the striatum; there, the increases were significant at 5 (+84%), 12 (+101%), and 21 (+45%) but not at 35 days postlesion. GLT1 immunostaining increased significantly and homogeneously by 17-26% at 12 and 21 days postlesion. The increase in GLT1 expression at 12 days postlesion was further confirmed by western blot analysis; in contrast, a 36% decrease in glutamate uptake activity was measured at the same time point. These data indicate that striatal GLT1 expression depends on corticostriatal but not thalamostriatal innervation. Comparison of our results with previous data showing that cortical lesion by aspiration downregulates striatal GLT1 expression further suggests that differential changes in GLT1 expression, and thus presumably in glial cell function, may occur in the target striatum depending on the way the cortical neurons degenerate.


Assuntos
Córtex Cerebral/fisiologia , Corpo Estriado/fisiologia , Proteínas de Transporte de Monossacarídeos/metabolismo , Tálamo/fisiologia , Vias Aferentes/fisiologia , Animais , Autorradiografia , Corpo Estriado/metabolismo , Denervação , Feminino , Transportador de Glucose Tipo 1 , Imuno-Histoquímica , Hibridização In Situ , Proteínas de Transporte de Monossacarídeos/genética , RNA Mensageiro/metabolismo , Ratos , Ratos Wistar , Distribuição Tecidual
5.
Neuropharmacology ; 38(3): 395-402, 1999 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-10219977

RESUMO

In this study, the effects of various agents known to alter protein phosphorylation, via protein kinase C or A, on high affinity glutamate uptake were investigated in primary neuronal cell cultures of rat cerebral cortex. Incubating the culture dishes with chelerythrine or H89 (N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide), which inhibit PKC and PKA, respectively, dramatically decreased the glutamate uptake in a dose-dependent manner. Saturation kinetic analysis showed that chelerythrine and H89 decreased the Vmax (chelerythrine: -61%, P < 0.06; -59%, P < 0.05) without affecting the Km of the transport process as compared to the control values. These inhibitory effects were counteracted by the corresponding protein kinase activators, i.e. PMA (phorbol-12-myristate 13-acetate) in the case of PKC and forskolin in the case of PKA, although these protein kinase activators alone did not significantly affect the glutamate uptake. These results provide evidence that, in primary cultures of neuronal cells, the high affinity glutamate uptake may be regulated by both PKA and PKC-mediated phosphorylation processes.


Assuntos
Córtex Cerebral/metabolismo , Proteínas Quinases Dependentes de AMP Cíclico/metabolismo , Inibidores Enzimáticos/farmacologia , Ácido Glutâmico/metabolismo , Isoquinolinas/farmacologia , Neurônios/metabolismo , Fenantridinas/farmacologia , Proteína Quinase C/metabolismo , Sulfonamidas , Alcaloides , Animais , Benzofenantridinas , Transporte Biológico/efeitos dos fármacos , Células Cultivadas , Córtex Cerebral/citologia , Colforsina/farmacologia , Feto , Cinética , Neurônios/citologia , Neurônios/efeitos dos fármacos , Ratos , Ratos Wistar , Acetato de Tetradecanoilforbol/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA